We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

81 hedge funds and large institutions have $158M invested in Fortress Biotech in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

290% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 10

264% more call options, than puts

Call options by funds: $20.3M | Put options by funds: $5.59M

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

19% more funds holding

Funds holding: 68 → 81 (+13)

12% more capital invested

Capital invested by funds: $141M → $158M (+$17.4M)

Holders
81
Holders Change
+13
Holders Change %
+19.12%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
39
Reduced
10
Closed
6
Calls
$20.3M
Puts
$5.59M
Net Calls
+$14.8M
Net Calls Change
+$13.9M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$11.9M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$11.3M
3
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$6.33M
4
CWAM
Columbia Wanger Asset Management
Illinois
+$4.29M
5
CIP
Chartwell Investment Partners
Pennsylvania
+$4.04M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$3.74M
2
SCM
Suffolk Capital Management
New York
-$3.21M
3
SC
Sophrosyne Capital
New York
-$1.59M
4
PC
PointState Capital
New York
-$1.32M
5
MCM
Montibus Capital Management
Oregon
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$813K +$138K +1,129 +17%
CS
27
Credit Suisse
Switzerland
$781K +$757K +6,175 +492%
ARTA
28
A.R.T. Advisors
New York
$729K +$850K +6,933 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$687K +$43.2K +352 +6%
PC
30
PointState Capital
New York
$617K -$1.32M -10,799 -65%
JAMONY
31
Jacob Asset Management of New York
California
$536K +$216K +1,760 +53%
BIM
32
BlackRock Investment Management
Delaware
$514K +$121K +986 +25%
Deutsche Bank
33
Deutsche Bank
Germany
$405K +$199K +1,620 +72%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$332K +$72K +587 +23%
TD Asset Management
35
TD Asset Management
Ontario, Canada
$311K +$27K +220 +8%
CCA
36
Catalyst Capital Advisors
New York
$302K +$351K +2,867 New
Charles Schwab
37
Charles Schwab
California
$299K – – –
TI
38
Turner Investments
Pennsylvania
$295K +$344K +2,805 New
EIM
39
Essex Investment Management
Massachusetts
$276K +$40.1K +327 +14%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$251K – – –
TA
41
Teachers Advisors
New York
$225K +$23.9K +195 +10%
Macquarie Group
42
Macquarie Group
Australia
$211K +$81.8K +667 +50%
Credit Agricole
43
Credit Agricole
France
$207K +$241K +1,965 New
SIP
44
Stoneridge Investment Partners
Pennsylvania
$198K +$50.6K +413 +28%
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$189K – – –
SG Americas Securities
46
SG Americas Securities
New York
$180K +$210K +1,712 New
EEG
47
E.E. Geduld
$175K -$81.7K -666 -29%
Morgan Stanley
48
Morgan Stanley
New York
$175K +$54.9K +448 +37%
NFA
49
Nationwide Fund Advisors
Ohio
$142K +$37.9K +309 +30%
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$141K -$736 -6 -0.4%
1
2
3 4

FBIO Hedge Fund Activity: Q3 2013 in Review

81 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2013, worth a combined $158M — up 12% from $141M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FBIO positions and 6 closed out — a net gain of 13 holders — while 39 added to existing stakes and 10 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $11.9M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $3.74M sold.

  • 81 institutional investors held Fortress Biotech (FBIO) as of Q3 2013, up from 68 in Q2 2013.
  • Funds reported $158M of Fortress Biotech stock for Q3 2013, up 12% quarter-over-quarter.
  • 19 funds opened new Fortress Biotech positions in Q3 2013 and 6 closed out, a net change of +13 holders.
  • The largest Fortress Biotech buyer in Q3 2013 was Fidelity Investments, an estimated $11.9M added.
  • The largest Fortress Biotech seller in Q3 2013 was Driehaus Capital Management, an estimated $3.74M sold.

Based on aggregated 13F filings for Q3 2013.